Literature DB >> 11230896

The impact of skin washing with water and soap during breast irradiation: a randomized study.

I Roy1, A Fortin, M Larochelle.   

Abstract

BACKGROUND: The effect of washing the irradiated skin during radiotherapy for breast cancer is uncertain. The purpose of this study was to evaluate the impact of washing the breast skin with water and soap during radiotherapy on the intensity of acute skin toxicity.
MATERIALS AND METHODS: Ninety-nine patients treated for breast cancer were prospectively randomized prior to receiving radiotherapy to the breast into two groups: (1), no washing was allowed during radiotherapy (49 patients); and (2), washing was allowed with water and soap (50 patients). Acute toxicity was recorded according to the Radiation Therapy Oncology Group (RTOG) acute skin toxicity scale for each patient every week during radiotherapy and 1 month after the end of radiotherapy. Symptoms related to skin toxicity were scored by visual analogue scales at the same time intervals. Other data collected included sociodemographic data, characteristics related to the tumor and previous treatments, radiation technique, necessity for a second simulation due to loss of skin marks and treatment interruptions.
RESULTS: In the non-washing group, the following maximum acute toxicity scores were observed: grade 0, 2%; grade 1, 41%; grade 2, 57%; grades 3 and 4, 0%. For the washing group, the scores were: grade 0, 0%; grade 1, 64%; grade 2, 34%; grade 3, 2%; and grade 4, 0%. Moist desquamation was seen in 33% of non-washing patients, but in only 14% of washing patients. The median scores of pain, itching and burning of the treated skin were higher in the non-washing group, although this was not statistically significant. In a multivariate analysis using logistic regression, acute skin toxicity was associated with the patient's weight, concomitant radiochemotherapy and hot spots on dosimetry, and there was a trend toward more acute skin toxicity in the non-washing group.
CONCLUSION: Washing the irradiated skin during the course of radiotherapy for breast cancer is not associated with increased skin toxicity and should not be discouraged.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230896     DOI: 10.1016/s0167-8140(00)00322-4

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  26 in total

1.  Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer.

Authors:  Simin Hemati; Omid Asnaashari; Mostafa Sarvizadeh; Behnam Nasiri Motlagh; Mojtaba Akbari; Mina Tajvidi; Abbas Gookizadeh
Journal:  Support Care Cancer       Date:  2011-10-19       Impact factor: 3.603

Review 2.  The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline.

Authors:  Amanda Bolderston; Nancy S Lloyd; Rebecca K S Wong; Lori Holden; Linda Robb-Blenderman
Journal:  Support Care Cancer       Date:  2006-06-07       Impact factor: 3.603

Review 3.  Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group.

Authors:  Rebecca K S Wong; René-Jean Bensadoun; Christine B Boers-Doets; Jane Bryce; Alexandre Chan; Joel B Epstein; Beth Eaby-Sandy; Mario E Lacouture
Journal:  Support Care Cancer       Date:  2013-08-14       Impact factor: 3.603

4.  Trolamine emulsion for the prevention of radiation dermatitis in patients with squamous cell carcinoma of the head and neck.

Authors:  Hamza Abbas; René-Jean Bensadoun
Journal:  Support Care Cancer       Date:  2011-02-22       Impact factor: 3.603

5.  Prone whole-breast irradiation using three-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent to good cosmetic outcomes in patients with large and/or pendulous breasts.

Authors:  Carmen Bergom; Tracy Kelly; Natalya Morrow; J Frank Wilson; Alonzo Walker; Qun Xiang; Kwang Woo Ahn; Julia White
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-28       Impact factor: 7.038

6.  Radiodermatitis prevention with sucralfate in breast cancer: fundamental and clinical studies.

Authors:  Sabrina Falkowski; Patrick Trouillas; Jean-Luc Duroux; Jean-Marie Bonnetblanc; Pierre Clavère
Journal:  Support Care Cancer       Date:  2009-12-09       Impact factor: 3.603

Review 7.  A systematic review of patient-rated measures of radiodermatitis in breast cancer radiotherapy.

Authors:  Julie B Schnur; Bianca Love; Bari L Scheckner; Sheryl Green; A Gabriella Wernicke; A Gabriella; Guy H Montgomery
Journal:  Am J Clin Oncol       Date:  2011-10       Impact factor: 2.339

8.  Topical use of a silymarin-based preparation to prevent radiodermatitis : results of a prospective study in breast cancer patients.

Authors:  Martina Becker-Schiebe; Ulrich Mengs; Margitta Schaefer; Michael Bulitta; Wolfgang Hoffmann
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

Review 9.  Management of normal tissue toxicity associated with chemoradiation (primary skin, esophagus, and lung).

Authors:  Victor Y Yazbeck; Liza Villaruz; Marsha Haley; Mark A Socinski
Journal:  Cancer J       Date:  2013 May-Jun       Impact factor: 3.360

10.  Protective effects of doxepin cream on radiation dermatitis in breast cancer: A single arm double-blind randomized clinical trial.

Authors:  Laleh Shariati; Alireza Amouheidari; Hajar Naji Esfahani; Alireza Abed; Shaghayegh Haghjooy Javanmard; Ismail Laher; Ahmad Ghasemi; Golnaz Vaseghi
Journal:  Br J Clin Pharmacol       Date:  2020-02-25       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.